INSMED
Insmed, Inc.
Application Filed: 2010-04-12
Trademark Application Details
ABANDONED - NO STATEMENT OF USE FILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85011369 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Peter J. Willsey |
| Attorney Docket Number | 315953-20000 |
| Law Office Assigned | M60 |
| Employee Name | MCMORROW, JANICE LEE |
Timeline
| 2010-04-12 | Application Filed |
| 2011-03-15 | Published for Opposition |
| 2012-06-01 | Location: INTENT TO USE SECTION |
| 2014-06-16 | Abandon |
| 2014-06-16 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Insmed, Inc. |
| Address | 9 Deer Park Drive, Suite C Monmouth Junction VA 08852 |
| Legal Entity Type | Corporation |
| Legal Entity State | VA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 16 |
| U.S. Codes: | 002,005,022,023,029,037,038,050 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical and biological preparations for clinical medical use, namely, for use in IGF-I deficiency, growth hormone insensitivity syndrome, growth disorders, severe burns, severe insulin resistance, Type 2 diabetes, Type 1 diabetes, muscular dystrophies, amyotrophic lateral sclerosis, retinopathy of prematurity, osteoporosis, and AIDS adipose redistribution syndrome; inoculations for use in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome; (syndrome X); polycystic ovary disease, infertility, hirsutism, hyperandrogenemia, severe burns, growth hormone insufficiency syndrome (GHIS also known as Laron Dwarfism), myotonic dystrophy, AIDS lipodystrophy, inflammatory disease, endocrine disease, reproductive disease, cancer, bacterial infection, viral infection, parasite infection, autoimmune disease, central nervous system disorders and neural tube defects; neutraceuticals for the treatment of type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome (Syndrome X), polycystic ovary disease, infertility, hirsutism, hyperandrogenemia and neural tube defects |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2010-04-15 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2010-04-15 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2010-07-19 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2010-07-21 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2010-07-21 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2010-07-21 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2011-01-05 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2011-01-05 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2011-01-05 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-01-06 | 10 CNSA P: |
| ASSIGNED TO LIE | 2011-02-04 | 11 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-02-04 | 12 PREV O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2011-03-07 | 13 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2011-03-07 | 14 ARAA I:Incoming Correspondence |
| PUBLISHED FOR OPPOSITION | 2011-03-15 | 15 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2011-03-15 | 16 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2011-05-10 | 17 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2011-11-07 | 18 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2011-11-07 | 19 EXT1 S: |
| EXTENSION 1 GRANTED | 2011-11-07 | 20 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2011-11-09 | 21 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2012-05-10 | 22 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2012-06-01 | 23 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2012-05-10 | 24 EXT2 S: |
| EXTENSION 2 GRANTED | 2012-06-04 | 25 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2012-06-05 | 26 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2012-11-01 | 27 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2012-11-01 | 28 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2012-11-08 | 29 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2012-11-08 | 30 EXT3 S: |
| EXTENSION 3 GRANTED | 2012-11-09 | 31 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2012-11-10 | 32 EXRA E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2013-04-16 | 33 TCCA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2013-04-17 | 34 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2013-04-17 | 35 EXT4 S: |
| EXTENSION 4 GRANTED | 2013-04-19 | 36 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2013-04-20 | 37 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2013-10-28 | 38 EEXT I:Incoming Correspondence |
| EXTENSION 5 FILED | 2013-10-28 | 39 EXT5 S: |
| EXTENSION 5 GRANTED | 2013-11-06 | 40 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2013-11-07 | 41 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2014-06-16 | 42 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2014-06-16 | 43 MAB6 O:Outgoing Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 